- Report
- June 2024
- 200 Pages
Global
From €7235EUR$7,950USD£6,203GBP
- Book
- November 2018
- 464 Pages
The Corneal Epithelial Defect market is a subset of the Optical market, focusing on the treatment of corneal epithelial defects. These defects can be caused by a variety of factors, including trauma, infection, and chemical or thermal burns. Treatment options include topical medications, contact lenses, and surgical procedures.
The market is composed of a variety of companies, ranging from pharmaceutical companies to medical device manufacturers. These companies develop and produce products such as topical medications, contact lenses, and surgical instruments. Additionally, there are companies that provide services such as corneal transplantation and laser vision correction.
Some companies in the Corneal Epithelial Defect market include Allergan, Bausch + Lomb, Johnson & Johnson, Novartis, and Santen Pharmaceuticals. Show Less Read more